An observational study in Postpartum, Opioid Use and Post-operative, sponsored by Northwestern University. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-02-25.
Sponsored by Northwestern University · Observational
This study seeks to investigate the prescribing patterns and patient utilization of opioid pain medication in the postpartum setting. Postpartum women will be surveyed prior to hospital discharge and again at 2-4 weeks postpartum in order to assess the number of opioid tablets they used (in relation to the number prescribed), pain satisfaction, and storage/disposal of any remaining opioid tablets.
Opiate abuse is a national epidemic and has paralleled the increase in opioid prescriptions, with diversion of surplus medication playing a key contributing role. As the majority of reproductive age women in the U.S. will experience childbirth, understanding opioid prescription patterns and patient opioid utilization in the postpartum period is critical.
Postpartum women will be recruited during a 9-month period to take part in pre-hospital discharge and 2-4 week postpartum surveys to prospectively assess opioid medication use with regard to quantity of opioid tablets prescribed and quantity used, storage and disposal of unused opioids and satisfaction with pain control.
Northwestern University is the lead sponsor of 1,420 studies on the registry; 199 are open to participants now.
Of its 103 completed or terminated interventional studies of FDA-regulated products, 75 (73%) have results posted.
Counted across the registry records on this site, refreshed daily.
Women who are postpartum
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Women who have undergone cesarean delivery
Other: Survey
Women who have undergone vaginal delivery
Other: Survey
A survey will be administered at two time points (time of hospital discharge and 2-4 weeks postpartum) to determine: * Satisfaction with pain control 2-4 weeks postpartum * Patient-reported use of opioid medication postpartum (receipt of prescription, filling of prescription, if refill was obtained, and number of opioid pills remaining at the time of follow-up) * Patient characteristics associated with high opioid use * Methods of storage and disposal of unused opioids
Also known as: Survey/Questionnaire
Postpartum outpatient opioid use
Self reported number of opioid tablets used at time of postpartum survey administered 2-4 weeks postpartum
Time frame: 8 weeks
Satisfaction with outpatient pain control
Satisfaction with pain control at the time of postpartum survey administered 2-4 weeks postpartum
Time frame: 8 weeks from time of hospital discharge
Proper disposal/storage of remaining opioid tablets
Proportion of patients who report proper disposal/storage of remaining opioid tablets at the time of postpartum survey administered 2-4 weeks postpartum
Time frame: 8 weeks from time of discharge
High opioid use
Comparison of characteristics of women with \>50% remaining versus \<50% remaining of prescribed opioid tablets
Time frame: 8 weeks from time of hospital discharge
Plan to share: No
This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.